THURSDAY MAY 6

7 a.m.-8:30 a.m.

Industry-Supported Breakfast Symposia

IS50. PTSD: Searching for Answers in Traumatic Times (Part 2) Supported by Cephalon Inc.

  A. Treatment and Prevention of Chronic PTSD: Psychosocial Approaches Edna B. Foa, Ph.D.

  B. Novel Drug Treatments for PTSD Beyond SSRIs Wei Zhang, M.D.

IS51. Bipolar Disorder in Women: Reproductive Implications of Treatment (Part 2) Supported by GlaxoSmithKline

  A. Use of Antiepileptic Medications in Women Martha J. Morrell, M.D.

  B. Reproductive Endocrine Consequences of Treatment Hadine Joffe, M.D.

7:30 a.m.-2 p.m.

Registration/Course Enrollment Open

8 a.m.-Noon

CME Courses 98-100

9 a.m.-10:30 a.m.

Lecture

L25. Through the Looking Glass: Uses of Simulation and Virtual Reality in Brain Imaging Research Godfrey D. Pearlson, M.D., Frontiers of Science Lecture Series

Master Educator Clinical Consultation

12. Iqbal Ahmed, M.D., on Psychiatric Disorders in the Elderly (Open to APA members only.)

Component Workshop

CW49. The Blame and Shame Game in Medical Errors: Do You Want to Play It? APA Committee on Patient Safety; Co-Chairpersons: Geetha Jayaram, M.D., Benjamin C. Grasso, M.D.

Issue Workshops

IW120. The Horns of a Dilemma: Myths and Realities of Drug-Industry Interaction Chairperson: John W. Burruss, M.D.

IW121. Group Psychotherapy With Substance Abusers American Group Psychotherapy Association; Co-Chairpersons: David W. Brook, M.D., Henry I. Spitz, M.D.

IW122. Milieu Therapies in the Age of Managed Care, Revisited Chairperson: C. Deborah Cross, M.D.

IW123. Psychiatric Consultation Reports in Minutes: Exploring New Technologies Chairperson: Henry H. Leung, M.D.

IW124. A Comprehensive Approach to the Treatment of Pain in HIV Illness Chairperson: David G. Krefetz, D.O.

IW125. Detection of Malingering Chairperson: Alan R. Hirsch, M.D.

IW126. Can Social Theory Be Integrated Into the Liberatory Goals of Psychiatry? Co-Chairpersons: Carl I. Cohen, M.D., Kenneth S. Thompson, M.D.

IW127. Treatment-Resistant Patients With Bulimia Nervosa Co-Chairpersons: Edi Cooke, Psy.D., Frampton Gwynette, M.D.

IW128. Leash on Life: Human Attachment to Animals Chairperson: Debra A. Katz, M.D.

IW129. Avoiding Dual-Agency Pitfalls of Work-Related Neuropsychiatric Impairments Chairperson: Harold J. Bursztajn, M.D.

IW130. Teaching Core Competencies: The Challenge for Academic Psychiatry Co-Chairpersons: Mary S. Sciutto, M.D., Mary E. Bongiovi-Garcia, M.D.

IW131. Keep It Real: Psychological Preparedness and Active-Coping Group Chairperson: Paula G. Panzer, M.D.

IW132. Psychiatric Aspects of Treating Primary Caregivers of Hospice Patients Co-Chairpersons: Jay L. Wung, M.D., Robert Taub, M.D.

IW133. Psychiatry Training for Primary-Care Physicians: What, How, and When? Chairperson: Hoyle Leigh, M.D.

IW134. Whose Responsibility Is It Anyway? The Treating Psychiatrist’s? Chairperson: Bernard J. Arseneau, D.O.

IW135. “Sad Days”: A Video of Psychiatric Problems in Afghanistan and Its Refugees Chairperson: Nigel M. Bark, M.D.

IW136. Program Evaluation Made Simple Co-Chairpersons: Barbara A. Johnson, M.D., James A. Schuster, M.D.

IW137. The Stalking Victim: Causes, Consequences, and Therapeutic Considerations Chairperson: Gail E. Robinson, M.D.

9 a.m.-Noon

Continuous Clinical Case Conference 2. Stuart C. Yudofsky, M.D., Richard L. Munich, M.D., Efram Bleiberg , M.D., Lauren B. Marangell, M.D., Alice Rogan, M.D., and Florence Kim, M.D. on Two Hospitalized Patients With Refractory Mood Disorder and Cognitive Impairment (Part 2) (Open to APA members only.)

Media Workshops

MW7. “Robot Stories”: Emotional and Ethical Challenges of a Technological Age Co-Chairpersons: Ravi Chandra M.D., John E. Beebe III, M.D.

MW8. Personality Disorders and the “Film Noir Femme Fatale”Chairperson: Scott Snyder, M.D.

11 a.m.-12:30 p.m.

Medical Update 4. Judith Korner, M.D., on How to Shrink Obesity

Scientific and Clinical Report Sessions

Session 28. Eating Disorders

83. Weight and Relapse to Cocaine and Alcohol Use in Patients With Eating Disorders Collaborative Session With the National Institute on Drug Abuse; Olivera J. Bogunovic, M.D.

84. DSM-IV Comorbidity in Binge-Eating Disorder Carlos M. Grilo, Ph.D.

85. Males at Risk: Hawaiian and Filipino Adolescents Alayne Yates, M.D.

Session 29. Addiction Psychiatry

86. PRISM-IV: Reliable Diagnosis in Alcohol and Drug Abusers Collaborative Session With the National Institute on Drug Abuse; Sharon Samet, M.S.W.

87. Cognitive Functioning: Predictors of Outcome in Cocaine-Dependent Patients Collaborative Session With the National Institute on Drug Abuse; Efrat Aharonovich, Ph.D.

88. Cocaine Expectancy Questionnaire: Psychometric and Underlying Model Collaborative Session With the National Institute on Drug Abuse; Marie C. Martin, Ph.D.

Session 30. Issues in Addictions

89. Psychosocial Therapies for Cocaine Dependence: A Controlled Study Collaborative Session With the National Institute on Drug Abuse; Adam J. Jaffe, Ph.D.

90. Patient Treatment Matching With Ambulatory Cocaine Abusers Charles H. Wilber, M.Ed.

91. Virtual Reality Cue-Reactivity-Controlled Trial for Nicotine Dependence Patrick S. Bordnick, Ph.D.

Session 31. Sleep and Seasonality

92. Modafinil Improves Patient Functioning in Shift-Work Sleep Disorder Milton K. Erman, M.D.

93. Modafinil Treatment of Chronic Shift-Work Sleep Disorder James K. Walsh, Ph.D.

94. A Comparison of Seasonality of Mood and Behavior in African and African-American Students Samina M. Yousufi, M.D.

Session 32. Issues in BPD

95. The Frequency of DSM-IV Personality Disorders in Psychiatric Outpatients Mark Zimmerman, M.D.

96. Inhibitory Functioning in BPD: An fMRI Study Sabine Herpertz

97. Life Changes, Social Adjustment, and Attempted Suicide in BPD and MDD Thomas M. Kelly, Ph.D.

Session 33. Consultation-Liaison Psychiatry

98. Depression and Nonlinear Heart Rate Dynamics in Older Coronary Patients Salvador M. Guinjoan, M.D.

99. The Role of Dexmedetomidine in Reducing Delirium in Cardiotomy Patients Jose R. Maldonado, M.D.

100. Psychiatry Training in Primary Care: Factors for a Satisfactory Program Hoyle Leigh, M.D.

Session 34. OCD

101. Self-Administered Versus Therapist-Administered Cognitive-Behavior Therapy for Medication Nonresponders With OCD David Tolin, Ph.D.

102. Effectiveness of Intensive Residential Treatment of Severe Refractory OCD S. Evelyn Stewart, M.D.

103. Hyperactive Error Processing in OCD Nicholas Maltby, Ph.D.

Session 35. Adult ADHD

104. Cognitive-Behavioral Therapy for Residual ADHD in Adults Steven A. Safren, Ph.D.

105. A Controlled Study of Functional Impairments in 500 ADHD Adults Stephen V. Faraone, Ph.D.

106. Long-Term Safety and Efficacy of Mixed Amphetamine Salts Extended-Release for Adult ADHD Joseph Biederman, M.D.

Issue Workshops

IW138. Diverse Cultural Expressions and Interventions for Anxiety and Depressive Disorders Chairperson: Nalini V. Juthani, M.D.

IW139. Spiritual and Religious Assessment in Clinical Practice Co-Chairpersons: Francis G. Lu, M.D., Christina M. Puchalski, M.D.

IW140. Long-Term-Care Insurance Denials to One-Time Psychiatric Patients Co-Chairpersons: Rita R. Newman, M.D., Ruth B. Kantor, M.D.

IW141. An Extension of the Analysis of Restorative Justice and Therapeutic Jurisprudence Co-Chairpersons: Lawrence K. Richards, M.D., Abraham L. Halpern, M.D.

IW142. Challenging Sleep Problems: Looking at Slow-Wave Sleep Chairperson: Lois E. Krahn, M.D.

IW143. Workplace Burnout in Psychiatrists: Evidence From the United Kingdom Co-Chairpersons: Alex P. Mears, Ph.D., John Sharkey, M.D.

IW144. Reactions After 9/11 in a Pretraumatized Community in the South Bronx Co-Chairpersons: Jeffrey M. Levine, M.D., Andreas Evdokas, Ph.D.

IW145. Treatment of Recent-Onset Schizophrenia in Community and Research Settings Chairperson: Raman C. Patel, M.D.

IW146. Evidence-Based Treatment for Schizophrenia in a Correctional Setting Chairperson: Larry H. Dizmang, M.D.

Noon-1:30 p.m.

Forum 12. APA and the Pharmaceutical Industry: An Open Forum Chairperson: Stephen M. Goldfinger, M.D.

Noon-2 p.m.

New Research Poster Session 10

2 p.m.-5 p.m.

Symposia

S90. New Clinical Indications for Light Treatment: Status Report

  A. Treatment of Winter Depression: Light or Drugs? Raymond W. Lam, M.D.

  B. Light Treatment for Antepartum Depression Katherine L. Wisner, M.D.

  C. Bright Light and Negative Ion Treatment for Chronic Depression Namni Goel, Ph.D.

  D. A Meta-Analysis of Light Treatment for Nonseasonal Depression Arja L. Tuunainen, M.D.

S91. Mood Disorders in Women Throughout the Life Cycle

  A. Pregnant Addicts Do Not Use Drugs Leslie H. Gise, M.D.

  B. Postpartum Psychosis: Phenomenology, Treatment, and Prevention Margaret G. Spinelli, M.D.

  C. Cyclic Moods and Acyclic Moods Kimberly A. Yonkers, M.D.

  D. The Greatest Experiment Ever Performed on Women Barbara Seaman, Ph.D.

S92. Overcoming Barriers to Long-Term Care and Treatment of the Elderly APA Corresponding Committee on Long-Term Care and Treatment for the Elderly

  A. An Inspirational Model of Care in Rural Long-Term-Care Facilities David W. Hodo, M.D.

  B. The PACE Model of Community-Based Care Robert K. Dolgoff, M.D.

  C. An Ethno-Cultural Model of Care in Long-Term-Care Facilities Ronald Brenner, M.D.

  D. Can You Ever Get Paid for Treating Patients in Long-Term-Care Settings? Istvan J.E. Boksay, M.D.

  E. Barriers to Psychiatric Care in Assisted-Living Facilities Helen H. Kyomen, M.D.

S93. Developmental Disabilities From Childhood to Adulthood

  A. Fetal Alcohol Spectrum Disorders for Mental Health Professionals: A Brief Review Paula J. Lockhart, M.D.

  B. Behavioral Interventions for Autism and Developmental Disorders in Adults Joel D. Bregman, M.D.

  C. Substance Use Disorders in Young Adults With and Without Learning Disabilities Joseph H. Beitchman, M.D.

  D. Psychopharmacology in Mental Retardation and Pervasive Developmental Disorders Bryan H. King, M.D.

S94. Update on Treatment of Stimulant Abuse Collaborative Session With the National Institute on Drug Abuse

  A. Recovery-Oriented Psychosocial Treatment Douglas M. Ziedonis, M.D.

  B. Therapy and Placement Approaches for Cocaine Abuse Treatments David R. Gastfriend, M.D.

  C. Pharmacological Treatment of Stimulant Abuse David A. Gorelick, M.D.

  D. Psychiatric Comorbidity in Stimulant Abusers Richard N. Rosenthal, M.D.

  E. Methamphetamine Abuse: 2004 Update Steven L. Batki, M.D.

S95. Depressive Personality Disorder Versus Dysthymic Disorder

  A. Conceptual Issues in the Overlap of Depressive Personality and Dysthymia Steven Huprich, Ph.D.

  B. Longitudinal Comparison of Depressive Personality Disorder and Dysthymic Disorder John C. Markowitz, M.D.

  C. Depressive Personality: 10-Year Follow-Up Daniel N. Klein, Ph.D.

  D. Impact of Comorbid Dysthymic Disorder on Outcome in Personality Disorders David J. Hellerstein, M.D.

  E. Clinical Correlates of Chronicity in Depression: Results From the Rhode Island MIDAS Project Mark Zimmerman, M.D.

S96. Behavioral Treatments for Drug Dependence Collaborative Session With the National Institute on Drug Abuse

  A. Durability of Cognitive-Behavioral Therapy Efficacy for Substance Abusers Bruce J. Rounsaville, M.D.

  B. HIV Risk Reduction and Substance Abuse Treatment George E. Woody, M.D.

  C. Low-Cost Contingency Management in Community Settings Nancy M. Petry, Ph.D.

  D. Cognitive-Behavioral Therapy and Naltrexone for Cocaine Dependence Joy M. Schmitz, Ph.D.

  E. Behavioral Family Counseling and Naltrexone for Male, Opioid-Dependent Patients William S. Fals-Stewart, Ph.D.

S97. Italian Psychiatry: 25 Years of Changes

  A. Italian Psychiatrists and Italian Psychiatry: 25 Years of Changes Mariano Bassi, M.D.

  B. Intensive Community Care: Is It the Same in Italy and the Rest of the World? Angelo Fioritti, M.D.

  C. Variations in Mental Health Service Provision in Italy and Their Links With Socioeconomic Predictors Giuseppe Tibaldi

  D. Residential Care in Italy: A National Survey Giovanni De Girolamo, M.D.

  E. Community Treatment of Schizophrenia in Italy Mirella Ruggeri, M.D.

S98. Withdrawn

S99. Mind, Brain, and Interpersonal Experience in Psychotherapy

  A. The Present Moment in Psychotherapy Daniel N. Stern, M.D.

  B. The Central Role of Emotion in Psychotherapy Diana Fosha, Ph.D.

  C. Intersubjectivity, Narrative, and the Brain in Psychotherapy Daniel J. Siegel, M.D.

S100. From Research to Clinical Practices in Treating Patients With BPD

  A. Levels of Care: A Scientific and Clinical Overview John G. Gunderson, M.D.

  B. Intensive Outpatient and Partial Hospital Care for BPD Anthony Bateman, M.D.

  C. Comparing Psychotherapies for Patients With BPD: A Progress Report Otto F. Kernberg, M.D.

  D. Effects of Psychotherapy on MDD in Patients With BPD Janine L. Stevenson, M.D.

  E. A Randomized Trial of Psychoeducation for Patients With BPD Mary C. Zanarini, Ed.D.

S101. Meaning in Suicide: Overcoming Barriers and Connecting Diverse Perspectives

  A. Existential Meaning: Unifying Diverse Perspectives to Understanding Suicide James R. Rogers, Ph.D.

  B. Meaning in Suicide From the Survivor’s Perspective Carla Fine, M.S.

  C. Approaches to Engaging People of Color in Program Initiatives for Suicide Prevention and Intervention Donna H. Barnes, Ph.D.

  D. Suicide: What Survivors Want From Mental Health Care Professionals Frank R. Campbell, Ph.D.

  E. The Clinician’s Perspective: Why Is This Subject So Tough for Us? Michael F. Myers, M.D.

S102. Individualizing Interpersonal Psychotherapy for Mood Disorders

  A. Interpersonal and Social Rhythm Therapy for Bipolar I Disorder Ellen Frank, Ph.D.

  B. Individualizing Treatment for Depressed Patients With Co-Occuring Panic or Anxiety Jill M. Cryanowski, Ph.D.

  C. Motivational Interviewing and IPT: An Approach to Treatment Engagement Holly A. Swartz, M.D.

  D. Group Psychotherapy for Infertile Women With Depression Ellen F. Olshansky, D.Sc.

S103. BDD: Is It a Mind, Body, or Sociocultural Problem, and How Do You Treat It?

  A. BDD: Phenomenology, Etiology, and Sociocultural Influences Sony Khemlani-Patel, Ph.D.

  B. How to Apply Cognitive and Behavior Therapy for BDD Fugen Neziroglu, Ph.D.

  C. Update on Pharmacotherapy for BDD Katharine A. Phillips, M.D.

  D. Cosmetic Surgery in BDD David Veale

  E. SNRI Treatment and Functional Imaging of BDD Eric Hollander, M.D.

S104. Model Psychiatry Residency Programs on Religion and Spirituality

  A. Religion, Spirituality, and Culture in Psychiatric Practice at the University of Louisville James Hyde, Ph.D.

  B. Enhancing Spirituality Teaching at the Medical University of South Carolina David W. Hiott, M.D.

  C. University of Saskatchewan Curriculum on Spirituality and Mental Health Marilyn D. Baetz, M.D.

S105. Health and Lifestyle of People With Schizophrenia: The View From Scotland

  A. Smoking Habits of Scottish People With Schizophrenia Ciara Kelly, M.D.

  B. Diet and Cardiovascular Risk: Descriptive Study and Randomized Controlled Trial Robin G. McCreadie, D.Sc.

  C. Ocular Abnormalities in Community-Based Patients With Schizophrenia Moira A. Connolly

  D. Sexual Dysfunction in Schizophrenia Shiona M. Macdonald, M.B.

  E. The Dental Health of People With Schizophrenia Robin G. McCreadie, D.Sc.

S106. Do Not Wait Until You Practice, Know It Now: What Residents and Early Career Psychiatrists Need to Know

  A. Professional Liability Insurance: A Primer for Psychiatrists Martin G. Tracy, J.D.

  B. Understanding Managed Care Shivkumar Hatti, M.D.

  C. Private Versus Administrative Versus Academic Practice David A. Baron, M.D.

  D. Ethics for Psychiatry Residents and Early Career Psychiatrists Thomas S. Newmark, M.D.

S107. Psychiatry, Ethics, and End-of-Life Care: New Insights and Challenges

  A. Impact of Demoralization on Decision Making in Physician-Assisted Suicide David W. Kissane, M.D.

  B. Spiritual Interpretation of the Demoralization Syndrome as Alienation From Self Constance A. Jennings, M.D.

  C. Countertransference and Ethical Issues in End-of-Life Care Brian J. Kelly, M.B.

  D. Competing Paradigms of Responding to Assisted-Suicide Requests in Oregon: Case Report N. Gregory Hamilton, M.D.

S108. An Integration of the Pathophysiology and Pharmacotherapy of PTSD

  A. Noradrenergic Function in the Pathophysiology and Treatment of PTSD Steven M. Southwick, M.D.

  B. Hypothalamic-Pituitary-Adrenal Axis and Serotonergic Function in PTSD J. Douglas Bremner, M.D.

  C. Amino Acid Neurotransmitter Modulation in PTSD Lori L. Davis, M.D.

S109. Feeling Unreal: A Contemporary Overview of Depersonalization Disorder

  A. The Phenomenology of Depersonalization Disorder Daphne Simeon, M.D.

  B. The Neurophysiological Basis of Depersonalization Disorder Anthony S. David, M.D.

  C. Neurobiology of the Dissociative States Produced by Ketamine John H. Krystal, M.D.

  D. Cognitive Processes in Depersonalization Disorder Orna Guralnik, Pys.D.

  E. Neurochemistry and Pharmacological Treatment of Depersonalization Disorder Daphne Simeon, M.D.

  F. A Cognitive-Behavioral Approach to Depersonalization Disorder Anthony S. David, M.D.

S110. Psychosocial Impact of SARS on Patients, Hospitals, and Health Care Providers

  A. The Traumatic Impact of SARS on Nurses and Health Care Workers With Children Robert G. Maunder, M.D.

  B. Academic Physicians Coping During SARS Donna E. Stewart, M.D.

  C. Consultation-Liaison Psychiatry During the SARS Outbreak: Response to Patients and Administration Jonathan J. Hunter, M.D.

  D. Psychosocial Effects of Quarantine Due to SARS in Health Care Workers Emma K. Robertson, Ph.D.

  E. Group Psychological Perspectives on the SARS Epidemic in Toronto Molyn Leszcz, M.D.

S111. Traumatic Stress: The Bridge Between Neuroscience and Psychodynamic Psychiatry

  A. Disorganized Attachment Alters the Cortisol Stress Response in Human Infants Robert D. Levitan, M.D.

  B. Biological Aspects of Intergenerational Responses to Traumatic Stress Rachel Yehuda, Ph.D.

  C. The Neurobiology of Cognitive Bias Andrei Novac, M.D.

  D. Psychodynamic Neurobiology Barton J. Blinder, M.D.

S112. Institutional Ethics in Psychiatry: A Multidisciplinary Perspective

  A. Ethical and Legal Aspects of Confidentiality in Psychiatric Institutions Rebecca W. Brendel, M.D.

  B. Institutional Obligation to Balance Science With Ethics in Research: Role of the IRB Scott E. Lukas, Ph.D.

  C. Some Functions of a Psychiatric Hospital Ethics Committee J. Alexander Bodkin, M.D.

  D. Ethical Roles, Identity, and Bureaucratic Health Care Jennifer Radden, Ph.D.

S113. The Effects of Sexual and Physical Abuse on Women’s Health

  A. The Lasting Effects of Sexual Abuse on Health: What Is the Evidence? Jane Leserman, Ph.D.

  B. The Health Impact of Sexual and Physical Abuse and PTSD Among Women With Pelvic Pain Samantha Meltzer-Brody, M.D.

  C. Does Having a Disability Increase Women’s Risk of Sexual and Physical Assault? Kathryn E. Moracco, Ph.D.

  D. Treating PTSD Related to Sexual Trauma in Women Marian I. Butterfield, M.D.

  E. Sexual Abuse in the Context of Psychiatric Disorders Anita L.H. Clayton, M.D.

S114. Providing Psychiatric Services Around the World With a Shortage of Psychiatrists The Royal College of Psychiatrists

  A. Peer-Specialists, Self-Help Groups, and Psychiatrists: An Opportunity to Expand Resources and Horizons Peter Stastny, M.D.

  B. The New U.K. Graduate Mental Health Worker Andrew Kent, M.D.

  C. Setting Up a Psychiatric Service for a Group of Afghan Refugees Living in Pakistan Khalid A. Mufti, M.D.

  D. Management of Mental Health Services With Scarce Resources: The Kenyan Experience Marx O. Okonji, M.A.

  E. The Marriage of Modern and Traditional Methods in Mental Health Care in Egypt Nasser F. Loza, M.B.

S115. Meeting The Challenge of Adolescent ADHD

  A. Functional Outcomes in Adolescents With ADHD Eric Mick, Sc.D.

  B. Diagnostic Issues: The Challenge of Adolescent ADHD Laurence L. Greenhill, M.D.

  C. Comorbidities in Adolescents With ADHD Joseph Biederman, M.D.

  D. Safety and Efficacy of OROS Methylphenidate in Adolescents With ADHD Timothy E. Wilens, M.D.

  E. Improvements in Adolescents’ Driving Performance With OROS Methylphenidate Daniel J. Cox, Ph.D.

S116. How to Practice Evidence-Based Medicine

  A. Introduction to Evidence-Based Medicine Bryce Templeton, M.D.

  B. Review of Basic Statistical Concepts Maju Mathews, M.D.

  C. Critical Appraisal of Randomized Controlled Trials Adedapo B. Williams, M.D.

  D. Critical Appraisal of Systematic Reviews and Meta-Analysis Babatunde A. Adetunji, M.D. ▪